Physician profile
Jan Hunt
NPI 1578903571
$1,486.13
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $49.70 · 2021: $240 · 2022: $914 · 2023: $50.60 · 2024: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $165.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $785.22 | 2022 | |
| Hologic Sales and Service, LLC | $127.97 | 2021-2024 | Myosure Tissue Removal Device, Acessa Provu System, Fluent Fluid Management System |
| Bayer Healthcare Pharmaceuticals INC. | $79.41 | 2020-2022 | |
| Abbvie INC. | $71.44 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $58.17 | 2020-2022 | |
| Evofem Biosciences, INC. | $55.51 | 2021 | |
| Roche Diagnostics Corporation | $52.51 | 2019-2021 | |
| Coopersurgical, INC. | $37.60 | 2019 | |
| Astellas Pharma US INC | $36.39 | 2024 | Veozah |
| Abbott Laboratories | $32.06 | 2021 | |
| Axonics, INC. | $30.43 | 2021-2022 | |
| Organon LLC | $23.24 | 2022-2024 | |
| Ethicon US, LLC | $21.38 | 2021 | |
| Myovant Sciences INC. | $20.08 | 2021 | |
| Amag Pharmaceuticals, INC. | $15.14 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $14.64 | 2021 | |
| Daiichi Sankyo INC. | $13.55 | 2021 | |
| Therapeuticsmd, INC. | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jan Hunt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.